Emmanuel L. Kuyinu

Emmanuel L. Kuyinu

Auto-generated profile, based on publicly available information

Emmanuel L. Kuyinu

Institute for Regenerative Engineering, University of Connecticut Health Center, Farmington, CT 06030, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2016 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
EKEmmanuel L. Kuyinu
Emmanuel L. Kuyinu
GNGanesh Narayanan
Ganesh Narayanan
LNLakshmi S. Nair
Lakshmi S. Nair
CLCato T. Laurencin
Cato T. Laurencin
Osteoarthritis (OA) is one of the most commonly occurring forms of arthritis in the world today. It is a debilitating chronic illness causing pain and immense discomfort to the affected individual. Significant research is currently ongoing to understand its pathophysiology and develop successful treatment regimens based on this knowledge. Animal models have played a key role in achieving this goal. Animal models currently used to study osteoarthritis can be classified based on the etiology under investigation, primary osteoarthritis, and post-traumatic osteoarthritis, to better clarify the relationship between these models and the pathogenesis of the disease. Non-invasive animal models have shown significant promise in understanding early osteoarthritic changes. Imaging modalities play a pivotal role in understanding the pathogenesis of OA and the correlation with pain. These imaging studies would also allow in vivo surveillance of the disease as a function of time in the animal model. This review summarizes the current understanding of the disease pathogenesis, invasive and non-invasive animal models, imaging modalities, and pain assessment techniques in the animals.

1 December 2016 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
GNGanesh Narayanan
Ganesh Narayanan
VVVaradraj N. Vernekar
Varadraj N. Vernekar
EKEmmanuel L. Kuyinu
Emmanuel L. Kuyinu
CLCato T. Laurencin
Cato T. Laurencin

14 February 2017 in Engineering
Verified
Journal Article
Open access
JIJorge L. Escobar Ivirico
Jorge L. Escobar Ivirico
MBMaumita Bhattacharjee
Maumita Bhattacharjee
EKEmmanuel Kuyinu
Emmanuel Kuyinu
LNLakshmi S. Nair
Lakshmi S. Nair
CLCato T. Laurencin
Cato T. Laurencin
Knee osteoarthritis (OA) is the most common form of arthritis worldwide. The incidence of this disease is rising and its treatment poses an economic burden. Two early targets of knee OA treatment include the predominant symptom of pain, and cartilage damage in the knee joint. Current treatments have been beneficial in treating the disease but none is as effective as total knee arthroplasty (TKA). However, while TKA is an end-stage solution of the disease, it is an invasive and expensive procedure. Therefore, innovative regenerative engineering strategies should be established as these could defer or annul the need for a TKA. Several biomaterial and cell-based therapies are currently in development and have shown early promise in both preclinical and clinical studies. The use of advanced biomaterials and stem cells independently or in conjunction to treat knee OA could potentially reduce pain and regenerate focal articular cartilage damage. In this review, we discuss the pathogenesis of pain and cartilage damage in knee OA and explore novel treatment options currently being studied, along with some of their limitations